CANNAPHARMARX, INC.

CPMD ·Healthcare, Drug Manufacturers - General
Financial Statements SEC Filings

SEC Filings

Form Filed Description
424B3 Aug 11, 2022 FORM 424(B)(3)
S-1/A Aug 9, 2022 AMENDMENT NO. 1 TO S-1
RW Aug 9, 2022 REQUEST FOR WITHDRAWAL
CORRESP Aug 8, 2022
S-1/A Aug 8, 2022 AMENDMENT NO. 1 TO S-1
UPLOAD Aug 8, 2022
S-1 Aug 1, 2022 FORM S-1
10-Q May 23, 2022 FORM 10-Q
NT 10-Q May 16, 2022 EXTENSION
10-K Apr 15, 2022 FORM 10-K
NT 10-K Mar 31, 2022
8-K Feb 16, 2022 FORM 8-K
10-Q Nov 15, 2021 FORM 10-Q
10-Q Aug 16, 2021 FORM 10-Q FOR JUNE 30, 2021
8-K Jul 16, 2021 FORM 8-K
8-K Jun 22, 2021 FORM 8-K
EFFECT Jun 11, 2021
424B3 Jun 10, 2021 FORM 424B3
CORRESP Jun 9, 2021
8-K Jun 9, 2021 CURRENT REPORT
CORRESP May 26, 2021
S-1/A May 26, 2021 FORM S-1- AMENDMENT 1
UPLOAD May 24, 2021
10-Q May 17, 2021 FORM 10-Q
S-1 May 14, 2021 FORM S-1
← Newer Page 3 of 14 · 338 filings Older →